VRTX US92532F1003

Rapport

Vertraagde tijd Nasdaq - 22:00 01-07-2022
287.32	USD		+1.96%

28/06	INSIDER VERKOOP : Vertex Pharmaceuticals	MT
13/06	VERTEX PHARMACEUTICALS : Een koopadvies van Cowen	MM
13/06	VERTEX PHARMACEUTICALS : Argus ontvangt een koopadvies	MM

Nieuws

Aanbevelingen van analisten

Andere talen

Persberichten

Officiële publicaties

Sectornieuws

Analyse MarketScreener

Nieuws in andere talen op VERTEX PHARMACEUTICALS

28/06	INSIDER SELL : Vertex Pharmaceuticals
15/06	TRANSCRIPT : Vertex Pharmaceuticals Incorporated Presents at Goldman Sachs 43rd Annual Glo..
13/06	Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up ..
11/06	Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up ..
10/06	Vertex Pharmaceuticals to Present Scientific Abstracts on Cystic Fibrosis Drugs at Euro..
10/06	Vertex to Present Data Demonstrating Significant Benefits of Long-Term and Early Treatm..
10/06	Vertex to Present Data Demonstrating Significant Benefits of Long-Term and Early Treatm..
08/06	Vertex to Participate in the Goldman Sachs 43rd Annual Healthcare Conference on June 1..
08/06	Vertex Pharmaceuticals Says US FDA Awards its Chronic Kidney Disease Treatment a Breakt..
08/06	Vertex Announces Inaxaplin (VX-147) Granted Breakthrough Therapy Designation by U.S. FD..
08/06	Vertex Pharmaceuticals Incorporated Announces Inaxaplin (VX-147) Granted Breakthrough T..
08/06	Lupin Gets US FDA Tentative Approval for Ivacaftor Tablets
07/06	Vertex présente de nouvelles données sur l'essai clinique de Phase 1 du VX-880 dans le ..
07/06	Vertex präsentiert neue Daten aus der klinischen Phase-1/2-Studie zu VX-880 bei den 82...
06/06	Vertex Pharma's Drug Candidate Improves Blood Glucose Control in Phase 1/2 Type 1 Diabe..
06/06	Vertex Presents New Data from VX-880 Phase 1/2 Clinical Trial at the American Diabetes ..
02/06	Vertex and CRISPR Therapeutics Announce Acceptance of Late-Breaking Abstract for CTX001..
31/05	Vertex to Present New Data on VX-880 Clinical Trial at 82nd American Diabetes Associati..
31/05	Vertex Pharmaceuticals Incorporated to Present New Data on VX-880 Clinical Trial
23/05	Top Midday Gainers
23/05	Catalyst Biosciences Stock Surges After Vertex Pharmaceuticals Buys Catalyst's Compleme..
23/05	Catalyst Biosciences Shares Soar After Complement Portfolio Sale
23/05	VERTEX PHARMACEUTICALS INC / MA : Other Events (form 8-K)
23/05	Catalyst Biosciences Sells Complement Portfolio for $60 Million
23/05	VERTEX PHARMACEUTICALS INCORPORATED : VRTX) acquired Complement Portfolio of Catalyst Bio..
19/05	Vertex Pharmaceuticals - Suketu Upadhyay Elected to Vertex Board of Directors
18/05	VERTEX PHARMACEUTICALS INC / MA : Submission of Matters to a Vote of Security Holders (for..
18/05	Suketu Upadhyay Elected to Vertex Board of Directors
18/05	Vertex Pharmaceuticals Incorporated Elects Suketu Upadhyay as Independent Director
17/05	Vertex Pharmaceuticals Pledges $50 Million to Health Equity
17/05	Vertex Announces Further Expansion in the Boston Seaport at Dedication of the Jeffrey L..
17/05	Vertex Pharmaceuticals Incorporated Announces Further Expansion in the Boston Seaport A..
17/05	Vertex Announces $50 Million Commitment to Health Equity With Three Initial Grants
06/05	VERTEX PHARMACEUTICALS INC / MA Management's Discussion and Analysis of Financial Cond..
05/05	Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Reports Q1 Revenue $2.1B, vs...
05/05	Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Reports Q1 EPS $3.52, vs. Str..
05/05	TRANSCRIPT : Vertex Pharmaceuticals Incorporated, Q1 2022 Earnings Call, May 05, 2022
05/05	Vertex Pharmaceuticals Q1 Results Rise; Reaffirms 2022 Product Revenue Guidance
05/05	VERTEX : Q1 Earnings Snapshot
05/05	Vertex Reports First Quarter 2022 Financial Results
05/05	Vertex Pharmaceuticals Incorporated Reiterates Earning Guidance for 2022
05/05	Vertex Pharmaceuticals Incorporated Reports Earnings Results for the First Quarter Ende..
05/05	EARNINGS REACTION HISTORY : Vertex Pharmaceuticals, 55.6% Follow-Through Indicator, 2.6% S..
02/05	Vertex Pharmaceuticals Says FDA Places VX-880 Diabetes Study on Clinical Hold; Shares D..
02/05	Vertex Provides Updates on Phase 1/2 Clinical Trial of VX-880 for the Treatment of Type..
02/05	Vertex Pharmaceuticals Incorporated Provides Updates on Phase 1/2 Clinical Trial of Vx-..
02/05	VERTEX PHARMA : FDA Puts VX-880 Diabetes Study on Hold
27/04	Big Biotech Firms Have Several Catalysts Lined Up, UBS Says
21/04	Vertex to Announce First Quarter 2022 Financial Results on May 5
21/04	VRTX - Health Canada Grants Marketing Authorization for TRIKAFTA (elexacaftor/tezacafto..
21/04	Vertex Pharmaceuticals Gets Canada's Approval of Trikafta for Children Aged Six to 11 Y..
20/04	Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivac..
20/04	Vertex Pharmaceuticals Incorporated Announces Health Canada Grants Marketing Authorizat..
18/04	INSIDER SELL : Vertex Pharmaceuticals
12/04	INSIDER SELL : Vertex Pharmaceuticals
12/04	INSIDER SELL : Vertex Pharmaceuticals
12/04	INSIDER SELL : Vertex Pharmaceuticals
11/04	INSIDER SELL : Vertex Pharmaceuticals
06/04	INSIDER SELL : Vertex Pharmaceuticals
05/04	INSIDER SELL : Vertex Pharmaceuticals
31/03	Vertex Pharmaceuticals Says Treatment for Pain After Certain Surgeries Met Primary Endp..
31/03	Vertex Announces Statistically Significant and Clinically Meaningful Results From Two P..
31/03	Vertex Pharmaceuticals Incorporated Announces Statistically Significant and Clinically ..
31/03	Vertex Pharmaceuticals to Advance VX-548 Pain Drug After Positive Phase 2 Studies
29/03	American Kidney Fund Announces Support from Vertex Pharmaceuticals Inc. to Raise Awaren..
28/03	Vertex Announces Reimbursement Agreement in Australia for TRIKAFTA for Patients With Cy..
26/03	Vertex Announces Reimbursement Agreement in Australia for TRIKAFTA® (elexacaftor/tezaca..
26/03	Vertex Pharmaceuticals Incorporated Announces Reimbursement Agreement in Australia for ..
25/03	Vertex Says Health Canada Gives Marketing Authorization to Expand Use of Kalydeco to Tr..
25/03	Health Canada Grants Marketing Authorization for KALYDECO® (ivacaftor) for Patients Wit..
22/03	Vertex Pharmaceuticals Advances Kidney Disease Treatment Candidate Into Pivotal Clinica..
22/03	Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated..
22/03	Vertex Pharmaceuticals Incorporated Advances VX-147 into Pivotal Clinical Development f..
21/03	INSIDER SELL : Vertex Pharmaceuticals
21/03	INSIDER SELL : Vertex Pharmaceuticals

1 2 3 4 5 6 7 8 9 10 Volgende

Officiële publicaties

06/05	SEC Filing 10Q-1
06/05	SEC Filing 8K
05/05	Press Release
05/05	1st quarter results
26/01	Press Release
26/01	Annual results

Meer Officiële publicaties

Volgende evenement op VERTEX PHARMACEUTICALS

27/07/22

Eerste halfjaar 2022 Cijferpublicaties (schatting)

De agenda van het bedrijf

Komende gebeurtenissen in de sector

27/07/22	GILEAD SCIENCES, INC. : Eerste halfjaar 2022 Cijferpublicaties (schatting)
04/08/22	REGENERON PHARMACEUTICALS, INC. : Eerste halfjaar 2022 Cijferpublicaties (schatting)
08/08/22	BIONTECH SE : Eerste halfjaar 2022 Cijferpublicaties
23/08/22	WUXI APPTEC CO., LTD. : Eerste halfjaar 2022 Cijferpublicaties (schatting)

Meer evenementen

Sector

Gezondheidszorg
	Farmaceutisch en medisch onderzoek
		Biotechnologie & Medisch Onderzoek
			Biotechnologie & Medisch Onderzoek
				Biotherapeutische geneesmiddelen